The SIA U.S. Health Care Providers ETF has shown strong resilience during the recent stock market selloff, rising within the SIA U.S. Equity Specialty ETF Report rankings. This positive relative strength signal from the ETF keeps us scanning for Health Care ideas across all SIA reports. Today, we’re highlighting CVS Health Corp. (CVS) for advisors’ attention.
Looking first at the point-and-figure chart for the iShares U.S. Health Care Providers ETF—used here as a proxy for the sector—we see a five-year range-bound pattern, with long-standing resistance at $58.49 and support at $47.04. We've also applied the SIA Matrix Position Overlay Tool, which has shown the Health Care sector in red for several years, indicating it was largely out of favor. However, this signal has now shifted to "favored" as the sector climbs the ranks into the green zone—a key development, though easily overlooked. The ETF currently holds a strong SIA SMAX rank of 8 out of 10, a short-term relative strength measure against other asset classes, which may suggest that money flows are returning to the Health Care sector after years of avoidance.
Next, we turn to CVS Health Corp. (CVS). Like the broader sector, CVS stock had been an underperformer for most of the past three years, falling from a high of $100 to a low of $43 in late 2024. However, momentum shifted in 2025. Shares are now up 56.11% year-to-date, 35.89% over the past quarter, and 5.36% in the past month—a period during which the broader U.S. stock market has declined.
For comparison, the S&P 100 Index (OEX.I) dropped -9.37% year-to-date, -8.15% over the past quarter, and -4.32% in the past month. This outperformance has elevated CVS within the SIA Relative Strength Matrices, moving it into the favored green zone in the SIA S&P 100 Index Report, as shown on the chart—progressing from red to yellow, and now to green.
Most recently, CVS shares registered another double top on the 2% point-and-figure chart, with next resistance levels at $77.91 and $81.06, and five-year support levels at $63.91 and $60.23. CVS currently holds a top-tier SMAX score of 10 out of 10, highlighting its strong relative outperformance compared to other asset classes.
Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.
